mcn 5691 has been researched along with Muscle Contraction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brannan, MD; Carson, JR; Damiano, BP; Flaim, SF; Gill, A; Gleason, MM; Hedberg, A; McCullough, JR; Shank, RP | 1 |
1 other study(ies) available for mcn 5691 and Muscle Contraction
| Article | Year |
|---|---|
Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Buffers; Calcium; Calcium Channel Blockers; Calcium Channels; Dose-Response Relationship, Drug; Guinea Pigs; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Potassium Channels; Propylamines; Rabbits; Rats; Rats, Inbred Strains; Rats, Inbred WKY; Receptors, Adrenergic, alpha | 1991 |